DXR (Daxor Corporation) Stock Financials & Earnings | Market Cap Arena

DXR (Daxor Corporation) Stock Financials & Earnings | Market Cap Arena

DXRDaxor Corporation

Mkt Cap$58M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Revenue (TTM)$917,257

Net Income (TTM)$10M

EPS (TTM)$1.92

Free Cash Flow (TTM)-$1M

Gross Margin66.1%

Op. Margin1219.0%

Net Margin1058.2%

FCF Margin-133.7%

P/S Ratio (TTM)63.0x

P/E Ratio (TTM)6.0x

YoY Rev Growth+132.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 20	$119K	$119K	-$104K
Q4 20	$145K	$145K	-$234K
Q2 21	$126K	$126K	-$297K
Q4 21	$152K	$152K	-$449K
Q2 22	$135K	$135K	-$236K
Q4 22	$96K	$96K	-$624K
Q2 23	$81K	$81K	-$366K
Q4 23	$82K	$82K	$3M
Q2 24	$72K	$72K	-$298K
Q4 24	$695K	$621K	$2M
Q2 25	$18K	$18K	-$269K
Q4 25	$132K	-$105K	$10M

Valuation

Quarter	P/S	P/E
Q2 20	82.7x	—
Q4 20	89.7x	—
Q2 21	100.2x	—
Q4 21	106.6x	19.0x
Q2 22	103.5x	12.1x
Q4 22	113.4x	5.8x
Q2 23	124.3x	6.9x
Q4 23	146.4x	10.6x
Q2 24	174.4x	10.3x
Q4 24	62.1x	70.8x
Q2 25	66.6x	16.6x
Q4 25	63.0x	6.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 20	-$1M	-$1M
Q4 20	-$2M	-$2M
Q2 21	-$1M	-$1M
Q4 21	-$1M	-$1M
Q2 22	-$2M	-$2M
Q4 22	-$2M	-$2M
Q2 23	-$3M	-$3M
Q4 23	-$4M	-$4M
Q2 24	-$894K	-$894K
Q4 24	-$502K	-$502K
Q2 25	$467K	$467K
Q4 25	-$297K	-$297K

Capital Expenditures

CapEx

Quarter	CapEx
Q2 20	$0
Q4 20	$0
Q2 21	$0
Q4 21	$0
Q2 22	$0
Q4 22	$0
Q2 23	$0
Q4 23	$0
Q2 24	$3
Q4 24	$3
Q2 25	$4
Q4 25	$4

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 20	-48.2%	+95.7%
Q4 20	-27.4%	+165.6%
Q2 21	-34.9%	+163.0%
Q4 21	-18.6%	+203.5%
Q2 22	+13.7%	+66.5%
Q4 22	-33.7%	+89.8%
Q2 23	-35.6%	+6.0%
Q4 23	-45.9%	-595.9%
Q2 24	-46.9%	-0.4%
Q4 24	+621.3%	-309.5%
Q2 25	-77.3%	-35.7%
Q4 25	+59.9%	-215.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 20	$82K	68.7%
Q4 20	$107K	73.6%
Q2 21	$183K	145.9%
Q4 21	$181K	118.9%
Q2 22	$138K	101.8%
Q4 22	$256K	265.1%
Q2 23	$162K	200.2%
Q4 23	$154K	186.4%
Q2 24	$276K	384.2%
Q4 24	$0	0.0%
Q2 25	$205K	1118.5%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M
Q2 20	$223K	—
Q4 20	$371K	—
Q2 21	$420K	—
Q4 21	$572K	—
Q2 22	$364K	—
Q4 22	$721K	—
Q2 23	$436K	—
Q4 23	$129K	$374K
Q2 24	$94K	$276K
Q4 24	$201K	$970K
Q2 25	$83K	$205K

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 20	$3M	$0	$3M
Q4 20	$618K	$0	$618K
Q2 21	$629K	$0	$629K
Q4 21	$711K	$0	$711K
Q2 22	$0	$0	$0
Q4 22	$0	$0	$0
Q2 23	$0	$0	$0
Q4 23	$0	$0	$0
Q2 24	$0	$0	$0
Q4 24	$0	$0	$0
Q2 25	$0	$0	$0
Q4 25	$0	$0	$0

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q2 20	4M	+0.0%
Q4 20	8M	+92.7%
Q2 21	8M	+0.0%
Q4 21	8M	+0.1%
Q2 22	8M	+0.1%
Q4 22	9M	+6.2%
Q2 23	7M	-23.0%
Q4 23	5M	-29.9%
Q2 24	5M	+4.3%
Q4 24	5M	+2.2%
Q2 25	5M	+1.0%
Q4 25	5M	+1.5%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	-$110K	37
FY 15	-$201K	37
FY 16	$50K	37
FY 17	-$27K	37
FY 18	-$25K	37
FY 19	-$3K	37
FY 20	-$76K	37
FY 21	-$71K	37
FY 22	-$10K	37
FY 23	$935K	37
FY 24	$58K	37
FY 25	$14K	37